Sumitomo Mitsui Trust Group Inc. Sells 843 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Sumitomo Mitsui Trust Group Inc. trimmed its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 0.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 636,733 shares of the company’s stock after selling 843 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Church & Dwight were worth $66,672,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of CHD. Strategic Financial Concepts LLC bought a new position in Church & Dwight during the 4th quarter valued at approximately $39,000. YANKCOM Partnership purchased a new position in shares of Church & Dwight during the fourth quarter valued at approximately $25,000. Bleakley Financial Group LLC raised its holdings in shares of Church & Dwight by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 27,159 shares of the company’s stock valued at $2,844,000 after acquiring an additional 346 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Church & Dwight by 29.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 34,662 shares of the company’s stock worth $3,665,000 after acquiring an additional 7,913 shares during the period. Finally, Weaver Capital Management LLC boosted its holdings in Church & Dwight by 3.3% in the fourth quarter. Weaver Capital Management LLC now owns 3,627 shares of the company’s stock valued at $380,000 after acquiring an additional 116 shares in the last quarter. 86.60% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CHD has been the subject of several research reports. TD Cowen upped their price objective on shares of Church & Dwight from $114.00 to $117.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Piper Sandler decreased their price target on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $105.00 price objective on shares of Church & Dwight in a research report on Monday, February 3rd. Deutsche Bank Aktiengesellschaft increased their target price on Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Finally, Barclays lifted their price target on Church & Dwight from $90.00 to $93.00 and gave the company an “underweight” rating in a research report on Tuesday, February 4th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. According to MarketBeat, Church & Dwight has an average rating of “Hold” and a consensus price target of $111.53.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $106.11, for a total transaction of $1,061,100.00. Following the transaction, the director now owns 32,500 shares in the company, valued at approximately $3,448,575. This represents a 23.53 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bradley C. Irwin sold 13,200 shares of Church & Dwight stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $107.44, for a total transaction of $1,418,208.00. Following the completion of the sale, the director now owns 37,169 shares of the company’s stock, valued at $3,993,437.36. This represents a 26.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 115,622 shares of company stock worth $12,842,559. Insiders own 2.00% of the company’s stock.

Church & Dwight Price Performance

Shares of NYSE:CHD opened at $105.05 on Monday. The company has a market capitalization of $25.74 billion, a PE ratio of 44.32, a PEG ratio of 3.35 and a beta of 0.59. The business has a fifty day moving average price of $105.87 and a 200-day moving average price of $104.36. Church & Dwight Co., Inc. has a 1-year low of $96.09 and a 1-year high of $113.50. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24.

Church & Dwight (NYSE:CHD) last issued its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the firm earned $0.65 earnings per share. As a group, equities analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be given a $0.295 dividend. The ex-dividend date is Friday, February 14th. This is a boost from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a yield of 1.12%. Church & Dwight’s dividend payout ratio is 49.79%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.